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Abstract 
 
A crucial part of the treatment of depression is the prevention of relapse and 
recurrence.  Psychological interventions, especially cognitive  behavior  therapy 
(CBT) are helpful in preventing relapse and recurrence in depression. The 
effectivity of four types of relapse prevention cognitive behavior therapy strategies 
will be addressed, i.e. acute prophylactic cognitive behavior therapy, continuation 
cognitive behavior therapy, sequential cognitive behavior therapy and cognitive 
behavior therapy in partial remission.  
Specific ingredients of three sequential cognitive behavior therapy programs 
(well-being  cognitive therapy,  preventive  cognitive therapy, and mindfulness-
based cognitive therapy) will be discussed as applied after remission in patients 
that  experienced previous  depressive episodes. Sequential preventive cognitive 
behavior therapy after acute treatment may be an attractive alternative treatment 
for many patients who currently use antidepressants for years and years to prevent 
relapse and recurrence. This is an extremely challenging issue to research 
thoroughly. Future studies must rule out what intervention for whom is the best 
protection against relapse and recurrence in depression. 
 
Keywords: major  depressive  disorder,  relapse, recurrence, cognitive behavior 
therapy, prevention, psychological interventions 
 
 
 
Major depressive disorder (MDD) was projected to rank second on a list of 15 
major diseases in terms of burden by the year 2030 (Mathers & Loncar, 2006). This 
major contribution of MDD to disability and medical costs is largely due to its 
highly recurrent nature (Murray & Lopez, 1997). Therefore, a crucial part of the PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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treatment of depression is the prevention of relapse and recurrence
1
This paper focuses on the enduring and preventive effects of cognitive behavior 
therapy (CBT) for relapse prevention of depression. Several types of relapse 
prevention programs can be differentiated. First, preventing relapse by the enduring 
and prophylactic effects of cognitive behavior therapy applied during the acute-
treatment phase. Second, preventing relapse by continuation-cognitive therapy in 
partly-recovered  or completely-recovered patients, during the maintenance and 
long-term follow-up phase after a treatment with cognitive behavior therapy in the 
acute depressive phase. Third, relapse prevention by starting sequential cognitive 
behavior therapy after remission in patients that did not get cognitive behavior 
therapy  in the acute phase. The latter intervention is typically provided to the 
patient after reaching remission status from the acute treatment. Fourth, relapse 
prevention in patient that are not fully remitted, i.e. partially remitted patients. In 
this paper the evidence for cognitive behavior therapy  as relapse prevention 
strategy will be discussed, followed by an overview of the main ingredients of 
primary sequential cognitive behavior therapy programs to prevent relapse will be 
discussed. 
. Both terms 
indicate a clinically significant deterioration in depressive symptoms meeting the 
criteria of a depressive episode according to DSM IV-TR (American Psychiatric 
Association, 2000) that followed a previous significant improvement (remission) of 
at least two months. 
 
Prophylactic Effects of Acute Cognitive Behavior Therapy 
 
Cognitive behavior therapy  interventions, applied in the acute phase of a 
depressive episode, have enduring effects that reduce risk of relapse following 
remission (e.g., for a meta-analysis see: Vittengl, Clark, Dunn, & Jarrett, 2007, for 
reviews see:  Dobson et al., 2008; Hollon, Stewart, & Strunk, 2005;  Kuyken, 
Dalgleish, & Holden, 2007;  Paykel, 2007).  In a meta-analysis of 28 studies, 
including 1,880 adults, Vittengl and colleagues (2007) reviewed the studies on 
cognitive behavior therapy  aimed at preventing relapse in major  depressive 
disorder. They included thirteen studies to examine the prophylactic effect of acute 
cognitive behavior therapy.  Their results indicated  that after discontinuation of 
acute-phase treatment, many responders to cognitive behavior therapy have lower 
relapse rates than those treated with antidepressants, but comparable to other 
depression specific psychotherapies. Overall,  these patients have still  relatively 
high relapse rates (29% within 1 year, and 54% within 2 years). 
Relapse proportions varied significantly between these studies reviewed by 
Vittengl et al. (2007). Factors that contribute to this include the following: the 
length of follow-up (higher relapse rates in studies with a longer follow-up); 
                                                 
1 Relapse and recurrence are used interchangeably PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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applied statistical procedure (survival analyses show higher relapse rates than 
analyses that merely compare proportions between conditions);  reported 
assessment of therapist competence and adherence (studies that report these aspects 
have lower relapse rates); and whether researchers used a relapse definition and 
assessment instrument specifically for this issue (mixed effects). Surprisingly, the 
high-relapse (versus other) subtype seemed not to moderate relapse differences (i.e. 
the effect) between these studies. The number of previous episodes of depression, 
however,  was consistently found to be a strong predictor of relapse in several 
studies
 (e.g., Kessing, Hansen, Andersen, & Angst, 2004; Mueller et al., 1999). The 
lack of moderation by relapse subtype could be explained by the dichotomous 
classification of subtype (high-relapse history  versus other), rather than by  the 
number of previous episodes. In addition, relatively few studies in this meta-
analysis included patients with a higher number of previous episodes. 
Overall, many studies indicate that acute-cognitive behavior therapy  has 
enduring effects, indicating that this psychological intervention might  indeed 
produce lasting change. These relapse-prevention effects for cognitive behavior 
therapy  seem to hold also  in  naturalistic,  "real world"  settings,  not just in the 
research, "university medical center" settings that are often used in randomized 
controlled trials (Minami et al., 2008). 
 
Continuation Cognitive Therapy 
 
A second type of relapse prevention  is  continuation-cognitive therapy  in 
recovered patients after a treatment with cognitive behavior therapy in the acute 
depressive phase. The recent meta-analysis by Vittengl and colleagues (2007) 
indicated that continuation-cognitive therapy reduced relapse from 21% reduction 
(assessment at the end of continuation-cognitive therapy) up to 29% reduction 
(assessment at the follow-up). Continuation-cognitive therapy also reduced relapse 
compared with other active continuation treatments, at the end of the continuation 
treatment (12% reduction) and at the follow-up (14% reduction).  
 
Sequential Cognitive Behavior Therapy 
 
The third type of relapse prevention is the sequential use of cognitive behavior 
therapy, after remission on diverse types of acute treatments (sometimes referred to 
as "relapse-prevention cognitive behavior therapy"). Studies on the effectiveness of 
relapse-prevention  cognitive behavior therapy  vary in the  acute-to-maintenance 
sequences that are used. Some studies focus on the effect of continuation-cognitive 
therapy after remission on acute-cognitive behavior therapy. In contrast, some other 
studies  switch  from acute-treatment  antidepressant  and remission to relapse-
prevention cognitive behavior therapy during the maintenance phase. In addition, 
some other studies have developed and evaluated relapse-prevention  cognitive 
behavior therapy during the maintenance and follow-up phase, regardless of the PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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type of treatment used in the acute phase. This last sequential strategy, applying 
cognitive behavior therapy after remission regardless of the type of prior treatment, 
may enhance generalizability of research results to daily clinical practice in primary 
care practices,  since the acute treatment of depression  varies  widely (Ebmeier, 
Donaghey, & Steele, 2006). 
Although all studies used relapse prevention cognitive behavior therapy  as 
main intervention strategy, certain  studies added extra ingredients (e.g., 
mindfulness, well-being, or rumination-focused cognitive behaviour therapy). For 
the sake of clarity, we will refer to all of these interventions as  variations of 
cognitive behavior therapy. 
One of the relapse prevention cognitive behavior programs that added extra 
ingredients is the mindfulness-based cognitive therapy (MBCT). Teasdale et al. 
(2000)
 reported that a sequential treatment with a version of cognitive behavior 
therapy  was effective for relapse prevention.  The treatment sequence was 
antidepressants during acute treatment and then a version of cognitive therapy – 
MBCT – following the successful acute treatment with antidepressants (N = 145). 
This study was replicated later, with an additional 75 patients (Ma & Teasdale, 
2004). Kuyken et al. (2008) recently compared in a randomized control trial (RCT) 
MBCT while tapering antidepressants against continuation of antidepressants in 
remitted recurrently depressed patients (N = 123). Relapse rates over 15 months for 
the MBCT group were not higher than for the antidepressants group (47% for 
cognitive therapy - CT, and 60% for the continuation of antidepressants group). In 
another,  randomized controlled trial  enrolling 172 remitted, but  recurrently-
depressed patients, the efficacy and  cost-effectiveness of  "preventive cognitive 
therapy" (PCT) was evaluated as an add-on to treatment-as-usual (TAU). PCT was 
also compared with TAU alone (Bockting et al., 2005). In line with the MBCT 
studies, PCT was effective (and "cost-effective" Bockting et al., under review) in 
preventing depressive relapses over a 2 year follow-up period, for patients with 
multiple previous episodes. TAU was less effective, and it included several types of 
aftercare:  antidepressants  during post-acute-treatment  (including non-controlled 
tapering of anti depressants), primary care, secondary care, and no care at all during 
the follow-up phase. Recently the enduring effect of PCT was demonstrated over 
5.5 years (Bockting, Spinhoven, Koeter, & Schene, 2009). 
In both the PCT study and the MBCT studies, the protective effect seemed 
absent for  patients with only  two previous episodes.  Strikingly, in these three 
studies also comparable main findings were reported, i.e. augmenting treatment as 
usual, with cognitive behavior therapy  (either PCT or MBCT) resulted in a 
significant protective effect, which intensified with the number of previous 
depressive episodes experienced by the patient (a well-known predictor of 
relapse/recurrence). The differences in relapse proportions between the conditions, 
however, at the point of three previous episodes, were small in all studies. In the 
PCT study, the estimated number of previous depressive episodes needed to benefit PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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from the cognitive behavior therapy intervention seemed somewhat higher (i.e., 
five-or-more previous episodes rather than three previous episodes, Bockting et al., 
2005; four of more over 5.5 years follow up, Bockting et al., 2009). The apparent 
indication of the number of episodes experienced for CT to be beneficial should be 
interpreted with caution because of the modest sample size. CT seemed to have no 
significant protective effect for patients with two previous episodes, in line with 
some other relapse prevention studies. Several explanations have been offered for 
this differential effect. The subtype hypothesis (Bockting et al., 2005; Teasdale et 
al., 2000) states that some category of depressions may be closely associated with 
reaction to life events, possibly reflecting the group of patients with fewer previous 
episodes in our study. The other type of depression may be brought about by 
rumination, reflecting the group of patients with a high number of episodes. 
Another hypothesis presumes that relapse/recurrence in patients with more previous 
episodes is thought to be attributable to autonomous relapse/recurrence processes 
involving reactivation of depressogenic thinking patterns by dysphoria. With 
repeated experiences of episodes of major depression, less environmental stress is 
required to provoke relapse/recurrence (Post, 1992). The prophylactic effect of CT 
(including mindfulness interventions) may arise from disruption of those processes 
at times of potential relapse/recurrence by reducing the extent to which patterns of 
depressive thinking reactivated by sad moods could feed factors responsible for 
relapse/recurrence (Segal, Williams, & Teasdale, 2002; Teasdale et al., 2000). It 
may be that the group of patients characterized by a lower age of onset, as 
previously reported (Bockting et al., 2005;  Ma  &  Teasdale, 2004)  and more 
previous episodes suffer  from a more biological subtype of depression, with a 
weaker link between stress and relapse/recurrence. 
Alternatively, the differential effect of relapse prevention CT could be simply 
explained by a time effect (in general a longer time to relapse in patients with two 
previous episodes) since other relapse prevention studies have a maximum of two-
year follow-up. Some support for this time effect has been reported over the 5.5 
follow-up study on PCT (Bockting et al., 2009) since the apparent indication of the 
number of episodes experienced for PCT to be beneficial seemed decreased 
compared to the two-year follow-up. 
A recent study indicated that behavioural activation might also be effective in 
preventing relapse (Dobson et al., 2008). Only one previous study (Petersen et al., 
2004) did not find a positive effect of cognitive behavior therapy (19 sessions in a 
half a year) on relapse prevention in depressed patients (N = 132). These patients 
achieved remission with the antidepressant  fluoxetine  (Prozac) and then  were 
randomised to receive cognitive behavior therapy and antidepressant medication 
versus antidepressant medication alone. Relapse rates were low in all groups. It is 
not clear why this one study, in contrast to many others, did not show a relapse-
prevention effect for cognitive behavior therapy. PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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In summary, studies indicate that  sequential  cognitive behavior therapy 
interventions overall have enduring effects that reduce the risk of relapse following 
the completion of acute-treatment. Recently, more evidence was obtained for the 
long-term  effects of sequential-cognitive behavior therapy,  over long follow-up 
intervals of 5.5 years (Bockting et al., 2009) and 3.5 to 5.5 years (Fava, Rafanelli, 
Grandi, Conti, & Belluardo, 1998b; Fava et al., 2004). In these studies, cognitive 
behavior therapy was used as a sequential treatment strategy, after acute treatment 
with antidepressants. In conclusion, sequential treatment where cognitive behavior 
therapy is started after remission, regardless of the acute treatment that is used, is an 
effective strategy to prevent relapse in high-risk patients for recurrence. Currently 
there is especially evidence for protective effects of cognitive behavior therapy for 
patients with at least two or three-or-more previous depressive episodes. Long term 
studies including at least 10 years of follow up are needed to rule out whether 
patients with fewer episodes can benefit from preventive psychological strategies. 
 
Cognitive Behavior Therapy in Partially Remitted Patients 
 
Sequential treatment where cognitive behavior therapy is offered to partially 
remitted patients is another type of relapse prevention that has been understudied. 
This group  of patient is at a very-high risk of relapse because of their partial 
recovery from the depressive episode.  A few studies indicate that cognitive 
behavior therapy also appears to be an effective relapse-prevention strategy (e.g., 
Kingston,  Dooley, Bates, Lawlor, & Malone  2007;  Paykel et al., 1999, 2005; 
Watkins  et al., 2007). Apart from evidence for traditional  cognitive behavior 
therapy in partially remitted patients (Paykel et al., 1999, 2005), modification of 
cognitive behavior therapy  have promising preliminary results in this partially 
remitted patient group. A  pilot  study  by Watkins et al. (2007)  evaluated 
"rumination-focused  cognitive behavior therapy"  (RFCBT),  that  emphases 
assessing, reducing, and coping with negative depressive ruminations. In their 
study, 12 weekly sessions of RFCBT was the relapse-prevention intervention for 14 
partially remitted  patients. The  investigators  reported  that  71%  of the patients 
showed a 50% reduction in depressive symptoms, and 50% of the patients achieved 
complete  remission  from their depressive episode (Watkins et al., 2007). The 
RFCBT  treatment  specifically focused on helping  patients  to switch from  less 
helpful to more helpful styles of thinking, using functional analysis, experiential-
imagery exercises,  and behavioral  experiments  regarding their negative 
ruminations. Although there results are promising replications in a larger sample 
are necessary with a long term follow up period before we can draw firm 
conclusions. 
Another example is a pilot study of Kingston et al. (2007) on the effects of 
MBCT for 19 recurrently-depressed patients (at least three previous episodes) with 
residual symptoms after acute treatment. Short-term follow-up results indicated that 
MBCT had a positive effect on the residual depressive symptoms, at the end the PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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MBCT intervention and at a 1-month  follow-up.  Again, replications in larger 
samples with a proper follow up are necessary before this can be applied in clinical 
practice for this specific patient group.  
 
Ingredients of Effective Sequential Relapse-prevention  
Cognitive Therapy in Remitted Patients 
 
The acute treatment of depression varies widely (Ebmeier, Donaghey, & 
Steele, 2006). Therefore the three  primary,  relapse-prevention  versions of 
sequential cognitive behavior therapy for remitted patients will be highlighted since 
applying  cognitive behavior therapy  after remission regardless of type of prior 
treatment is very useful for daily clinical practice. Specific characteristics of each 
intervention will be discussed. These versions of cognitive behavior therapy are 
typically  focused on remitted patients with a history of multiple depressive 
episodes. The three versions of cognitive behavior therapy are: well-being CBT 
(WBCT), preventive CT (PCT), and mindfulness-based CT (MBCT). 
 
Well-Being CBT 
 
Fava  and colleagues  (1998a,  1998b,  2004)  have  studied a sequential 
psychological  treatment that  is  applied after a successful treatment with 
antidepressant medication in the acute phase of depression, i.e. well-being CBT. 
Well-being CBT significantly reduced depressive relapse in patients with at least 
three previous episodes (Fava et al., 1998a, 1998b, 2004). Well-being cognitive 
therapy includes specific psychological interventions with some cognitive behavior 
therapy  elements, like life-style modification and well-being  therapy  (cf.  Fava, 
1999a,  1999b).  In their treatment protocol, well-being  CBT  extends over 8 
individual sessions (once a week, 30-50 minutes each). As is common in cognitive 
behavior therapy, a structured diary is used as part of the patient’s homework. This 
approach emphasizes the interaction between patients and therapists, along with 
other issues in the "therapeutic alliance." Well-being CBT is structured, directive, 
problem-focused, and based on an educational model of therapeutic intervention. 
Well-being CBT is based, in part, on Ryff’s cognitive model of "psychological 
well-being" (Ryff, 1989). This conceptual framework focuses on six potential well-
being  impairments:  (a)  Environmental  mastery:  this impairment refers to the 
patient’s feeling of lack of control and attributing negative outcomes to their own 
self,  while  attributing  positive achievements  to external factors; (b) Personal 
growth:  this  impairment reflects the patient’s  inability to learn from previous, 
successfully handled experiences, and then use this skill for future experiences 
(also called "transfer of experiences;" see: Fava, 1999a, 1999b); (c) Purpose of life: 
this impairment reflects the patient’s lack of direction and purpose in life, which is 
often accompanied by a sense of self-devaluation; (d) Autonomy: this impairment 
can reflect the patient’s perceived lack of self-worth, and it may lead to unassertive PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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behavior or avoidance; (e) Self-acceptance: this impairment refers to the patient’s 
perfectionist  attitudes, which may lead to unrealistically-high standards and 
expectations.  Well-being is harmed or at least neutralized by a chronic 
dissatisfaction with self; and (f) Positive relations with others: this last impairment 
builds on the others  so that the patient may create unrealistic expectations for 
intimate relationships and friends,  or  simply avoid intimate  and other close 
relationships. Although there are, some similarities between these formulated well-
being CBT impairments and "standard cognitive behavior therapy". Well-being 
CBT has been described as having its own style and way of emphasizing these 
themes (Beck, Rush, Shaw, & Emery 1979; Clark & Beck, 1999; Fava, 1999a; 
Fava, 1999b; Fava et al., 1998a, 1998b, 2004). 
The first sessions of  well-being CBT  usually  focus on encouraging and 
teaching  patients to keep a diary, which emphasizes the circumstances of 
experiences with well-being. The diary may include a concrete rating system as is 
common in cognitive behavior therapy  (e.g., a 0-100 rating scale for  specific 
thoughts and behaviors).  Thereafter,  the  patients  are  encouraged to identify 
thoughts, emotions, and behaviors that lead to a decrease in their sense of well-
being.  Then  these  thoughts  and associated emotions and behaviors can be 
discussed, evaluated, and possibly modified. In addition, patients are encouraged to 
increase activities that promote  positive  well-being (including graded-task 
assignments and homework common in standard cognitive behavior therapy). In 
the final sessions of well-being CBT, errors in thinking and alternative and more 
functional thinking styles are discussed further; then the therapist and patient work 
on solidifying these  positive changes.  Moreover, the diary, self-monitoring, 
homework, and therapy discussions all facilitate assessment and change, again 
within the six conceptual areas of well-being  impairment.  It should be 
acknowledged that "standard cognitive behavior therapy techniques" are also used, 
such as cognitive restructuring (modification of automatic and irrational thoughts), 
scheduling of positive activities (mastery, pleasure, and graded-task assignments), 
assertiveness training,  and  problem-solving  strategies.  In summary, well-being 
CBT is an interesting modification of standard CBT procedures for depression, that 
has been successfully used in some randomized controlled trials, and which was 
developed specifically with relapse-prevention in mind. 
 
Preventive Cognitive Therapy (PCT) 
 
PCT is a modified form of standard cognitive behavior therapy that was also 
specifically developed to prevent relapse in recurrent depression and was adapted 
for remitted high risk patients (Bockting et al., 2005). It is usually conducted in a 
group-therapy format, with eight weekly, two-hour sessions. The group typically 
has 7 to12 members and a specifically trained therapist. The relapse-prevention 
program of PCT targets, in particular, underlying cognitive vulnerability factors 
that are "depressogenic assumptions/beliefs" and that thought of as vulnerability PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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factors for relapse (Beck, 1987). Compared to standard cognitive behavior therapy 
for acutely-depressed patients (e.g., Beck et al., 1979), however, PCT for relapse-
prevention is less focused on modifying a wide range of negative and dysfunctional 
thoughts in the here and now. Instead, it is mainly focused right from the beginning 
on the identification of dysfunctional attitudes/assumptions/beliefs, aided by a self-
report questionnaire that includes concrete examples. After identification of these 
attitudes and beliefs it is directed towards challenging these specific attitudes and 
beliefs, especially using a wide array of cognitive techniques, such as Socratic 
questioning and the identification of certain positive attitudes (‘dream beliefs’ as 
demonstrated by Padesky).  The content  and style of these PCT  techniques  is 
brought into close alignment with the dysfunctional thinking styles that are 
predominantly latent in this remission phase, but easily activated. As is common in 
cognitive behavior therapy  patients are constantly  encouraged to practice in 
between the sessions with the new material. 
Remitted, but recurrently-depressed patients, often have an inability to retrieve 
specific memories from the past and this is associated with impaired problem-
solving skills (e.g., Pollock & Williams, 2001), long-term course of depressive 
disorders (e.g.,  Peeters,  Wessel, Merkelbach, & Boon-Vermeeren,  2002),  and 
difficulties staying recovered from depression (e.g., Brittlebank, Scott, Williams, & 
Ferrier, 1993). Therefore, patients are asked to keep a diary of positive experiences 
in order to enhance the storage and retrieval of specific  memories of positive 
experiences, rather than focusing on many general and vague memories, some of 
which may be negative. 
In addition, in the last group sessions an individual prevention plan is designed 
and discussed that captures warning signals for relapse, known psychological 
vulnerability factors and expected stressful events and, last, helpful strategies will 
be formulated. 
In summary, PCT is a modification of standard cognitive behavior therapy 
techniques  for depression, developed specifically for relapse prevention, and 
conducted in a group-therapy format after the completion of divers type of acute 
treatments.  
 
Mindfulness-Based Cognitive Therapy (MBCT) 
 
Kabat-Zinn and his colleagues were among the first to introduce the concept of 
"mindfulness" into  healthcare  settings,  in the 1980s  (Kabat-Zinn, 1982; Kabat-
Zinn, Lipworth, & Burney, 1985). They used this approach for the treatment of 
chronically-ill patients, patients with severe  pain,  and  patients with anxiety 
disorders (e.g., Kabat-Zinn, 1982; Kabat-Zinn, Lipworth, & Burney 1985; Kabat-
Zinn et al., 1992).  Segal, Williams,  and Teasdale (2002)  and colleagues have 
adapted "mindfulness training" as a strategy to prevent relapse in depression. They 
call this strategy mindfulness-based CT (MBCT). They, and others, have evaluated PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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this strategy in a series of randomized controlled trials (e.g., Kuyken et al., 2008; 
Ma & Teasdale, 2004; Teasdale et al., 2000, 2001). In MBCT, standard cognitive 
behavior therapy  interventions are combined with  "mindfulness meditation." 
Mindfulness is essentially a non-judgmental, but keen awareness, of the present 
moment and current environment. Meditation techniques are practiced in order to 
prevent negative rumination. The aims of MBCT include helping patients who have 
suffered from depression learn skills that prevent depressive relapse. These skills 
include becoming more aware of bodily sensations, feelings, and thoughts from 
moment-to-moment. Thus, the patients learn to react, and relate, to their emotions 
and thoughts in a more-positive way, with an acceptance and acknowledgement of 
the unwanted feelings and thoughts. This mindfulness-based perspective also helps 
patients to view this as something that just happens to them, rather than something 
that implies negative things about their own self. Furthermore, this mindfulness-
based perspective helps patients to select and implement more skillful responses to 
the unpleasant thoughts, and move on. 
MBCT includes 8-10 weekly sessions, each lasting 2 hours. The sessions tries 
to  teach patients to shift from a 'doing'  mode to a 'being'  mode,  by applying 
mindfulness meditation practice, body scan techniques,  and mindful-movement 
training. Learning to pay attention is the focus of the first few sessions. Patients 
learn to become aware of how the mind is wandering and to bring it back to the 
body or another single focus. Handling mood shifts now or dealing with them later 
is dealt with in the next few sessions. Patients learn to move their attention to their 
breathing and later to expand their attention to their body as a whole, which is 
thought of as an essential step in effectively dealing with difficulties. In line with 
PCT, in the last session of MBCT, patients are also encouraged to become more 
aware of their personal warning signs of impending depression, and to develop 
specific plans for when this might occur. Patients are also asked to practice daily 
meditation at home. 
 
 
Conclusion 
 
Overall, maintenance treatment with antidepressant medication is the most-
common strategy to prevent relapse in patients with recurrent major depressive 
disorder  (e.g.,  American Psychiatric Association, 2008; Geddes et al.,  2003; 
National Institute for Clinical Excellence, 2009). A recent meta-analysis, however, 
illustrates that the success rates for long-term antidepressants should be cautiously 
interpreted.  In this study by Turner and colleagues, they reported  an  over-
estimation of the effect size for antidepressants of 32%, which was apparently due 
to "publication bias", i.e. only the more positive outcomes were published (Turner, 
Matthews, Linardatos, Tell, & Rosenthal 2008).  In addition, previous studies, 
indicated that many depressed patients in Europe (up to 70%)  who are being 
treated in primary care settings are not willing to take antidepressant medications PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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after remission; or, these patients  take too-low dosages  for treatment efficacy 
during the follow-up phase (e.g.,  Bockting et al., 2008; Meijer et  al.,  2004). 
Therefore, maintenance cognitive behavior therapy  (e.g., relapse-prevention 
cognitive behavior therapy) after acute treatment may be an attractive alternative 
treatment for many patients, and there is some support for this (e.g., Blackburn & 
Moore, 1997; Kuyken et al., 2008). This is an extremely challenging issue to 
research  thoroughly,  however, and more large studies are needed.  Currently, 
Kuyken is replicating his first study in the UK and in the Netherlands a national 
study is undertaken that compares PCT while tapering antidepressants against the 
combination of PCT with antidepressants versus continuation of antidepressants 
alone (Bockting et al., submitted a). 
The research completed so far suggests that cognitive behavior therapy 
programs aimed at preventing relapse do reduce depressive relapse. New studies 
on sequential cognitive behavior therapy should investigate, among other things, 
the underlying mechanisms of these preventive treatments. For example, further 
process studies are needed to evaluate the claims that the additions to standard 
cognitive behavior therapy programs, such as meditation training (MBCT) and 
well-being training (WBCT), are essential for an effective relapse prevention 
program. In addition, research should focus on who benefits the most from various 
cognitive behavior therapy relapse-prevention strategies.  
 
Minimal Interventions? 
 
Given the high prevalence of major depressive disorder, new intervention with 
minimal therapist support,  deserve more attention, such as cognitive behavior 
therapy-type programs specifically aimed at preventing relapse that are delivered 
over the Internet. At the moment, a national study is undertaken in the Netherlands 
on the effect of an intervention offered over the internet with minimal therapist 
support based on the face to face PCT program (Bockting et al., submitted b). 
Overall, a depressive relapse is for most an awful experience, especially if it is 
happening  repeatedly.  Cognitive behavior therapy  offers an effective  treatment 
option for relapse prevention, with considerable support from meta-analysis and 
randomized controlled trials.  Especially the brief sequential cognitive behavior 
therapy, as applied after remission, regardless of prior treatment, seems a cost 
effective, easily implemented intervention to prevent relapse in high-risk groups. 
Since many remitted patient have no treatment in secondary care, implementation 
in primary care (in general practitioner’s practices) is recommended. 
Sequential  cognitive behavior therapy  might be alternative to long-term 
antidepressant treatment and for some patients a complementary intervention with 
antidepressant treatment is the best option. Future studies must rule out what 
intervention for whom is the best protection against relapse. 
 PSYCHOLOGICAL TOPICS 19 (2010), 2, 273-287 
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